@article{24eeda7f492a4de885cdca003011f003,
title = "Exploring the Nexus of Binge Eating Disorder (BED), New Psychoactive Substances (NPS), and Misuse of Pharmaceuticals: Charting a Path Forward",
keywords = "semaglutide, glucagon-like peptide-1 (GLP-1) agonists, binge eating disorder (BED, New Psychoactive Substances (NPS), drug misuse, drug abuse, pharmacovigilance, image- and performance- enhancing drugs (IPEDs)",
author = "Stefania Chiappini and {Papanti Pelletier}, {G. Duccio} and Rachel Vickers-Smith and John Corkery and Amira Guirguis and Giovanni Martinotti and Fabrizio Schifano",
note = "{\textcopyright} 2023 Informa UK Limited, trading as Taylor & Francis Group. This is the accepted manuscript version of an editorial which has been published in final form at https://doi.org/10.1080/14656566.2023.2271389",
year = "2023",
month = oct,
day = "31",
doi = "10.1080/14656566.2023.2271389",
language = "English",
pages = "1--4",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor & Francis Group",
}